Peter Lembessis

1.9k total citations
63 papers, 1.5k citations indexed

About

Peter Lembessis is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Peter Lembessis has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Peter Lembessis's work include Bone health and treatments (10 papers), Cancer Cells and Metastasis (9 papers) and Prostate Cancer Treatment and Research (9 papers). Peter Lembessis is often cited by papers focused on Bone health and treatments (10 papers), Cancer Cells and Metastasis (9 papers) and Prostate Cancer Treatment and Research (9 papers). Peter Lembessis collaborates with scholars based in Greece, Canada and United States. Peter Lembessis's co-authors include Michael Koutsilieris, Nikolaos Pissimissis, Antigone Sourla, Petros Tsipouras, Michael W. Kilpatrick, Jack Thomas, Frank P. Luyten, Ludwig Erlacher, Teresa Costa and John Macleod and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and Annals of the New York Academy of Sciences.

In The Last Decade

Peter Lembessis

62 papers receiving 1.5k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Peter Lembessis	693	394	282	248	182	63	1.5k
Hideo Takeshima	765 1.1×	248 0.6×	219 0.8×	317 1.3×	180 1.0×	123	2.3k
I G Rennie	831 1.2×	680 1.7×	188 0.7×	186 0.8×	135 0.7×	136	2.8k
Ying Shen	791 1.1×	397 1.0×	185 0.7×	145 0.6×	91 0.5×	39	1.7k
Božo Krušlin	689 1.0×	444 1.1×	273 1.0×	488 2.0×	90 0.5×	158	1.7k
Zhengjian Yan	1.1k 1.6×	240 0.6×	328 1.2×	115 0.5×	189 1.0×	44	2.1k
Kaori Fujita	1.1k 1.5×	467 1.2×	313 1.1×	142 0.6×	107 0.6×	45	1.7k
Eul‐Ju Seo	796 1.1×	285 0.7×	106 0.4×	157 0.6×	417 2.3×	116	1.9k
Jingxin Qiu	877 1.3×	346 0.9×	310 1.1×	216 0.9×	174 1.0×	76	1.8k
P. C. Marchisio	1.2k 1.7×	343 0.9×	328 1.2×	104 0.4×	129 0.7×	39	2.7k
Yakov Fellig	934 1.3×	183 0.5×	611 2.2×	168 0.7×	155 0.9×	78	1.8k

Countries citing papers authored by Peter Lembessis

Since Specialization

Citations

This map shows the geographic impact of Peter Lembessis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lembessis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lembessis more than expected).

Fields of papers citing papers by Peter Lembessis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lembessis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lembessis. The network helps show where Peter Lembessis may publish in the future.

Co-authorship network of co-authors of Peter Lembessis

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lembessis. A scholar is included among the top collaborators of Peter Lembessis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lembessis. Peter Lembessis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chrysavgis, Lampros, et al.. (2023). Significance of Circulating Cell-Free DNA Biomarkers in HBeAg-Negative Chronic Hepatitis B Virus Infection and Their Changes after Treatment Initiation. Pathogens. 12(3). 394–394.

Chatzigeorgiou, Antonios, Lampros Chrysavgis, Peter Lembessis, et al.. (2020). Circulating cell‐free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients. Journal of Viral Hepatitis. 28(3). 464–474. 6 indexed citations

Katsarou, Angeliki, et al.. (2020). Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease. World Journal of Gastroenterology. 26(17). 1993–2011. 72 indexed citations

Chatzigeorgiou, Antonios, et al.. (2009). CD40 Expression and its Association with Low-grade Inflammation in a Greek Population of Type 1 Diabetic Juveniles: Evidence for Differences in CD40 mRNA Isoforms Expressed by Peripheral Blood Mononuclear Cells. Experimental and Clinical Endocrinology & Diabetes. 118(1). 38–46. 18 indexed citations

Lembessis, Peter, et al.. (2009). Detection of Circulating Tumor Cells in Prostate Cancer Patients: Methodological Pitfalls and Clinical Relevance. Molecular Medicine. 15(3-4). 101–114. 87 indexed citations

Halapas, Antonios, Achilleas Zacharoulis, Stamatios Theocharis, et al.. (2008). Serum levels of the osteoprotegerin, receptor activator of nuclear factor κ-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction. Clinical Chemistry and Laboratory Medicine (CCLM). 46(4). 510–6. 17 indexed citations

Nezos, Adrianos, Peter Lembessis, Antigone Sourla, et al.. (2008). Molecular markers detecting circulating melanoma cells by reverse transcription polymerase chain reaction: methodological pitfalls and clinical relevance. Clinical Chemistry and Laboratory Medicine (CCLM). 47(1). 1–11. 27 indexed citations

Halapas, Antonios, et al.. (2008). Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications. Expert Opinion on Therapeutic Targets. 12(7). 821–836. 2 indexed citations

Pissimissis, Nikolaos, et al.. (2008). The kisspeptin (KiSS-1)/GPR54 system in cancer biology. Cancer Treatment Reviews. 34(8). 682–692. 77 indexed citations

10.

Koutsilieris, Michael, Constantine Milathianakis, John Bogdanos, et al.. (2007). Combination of somatostatin analogues and dexamethasone (antisurvival‐factor concept) with luteinizing hormone‐releasing hormone in androgen ablation‐refractory prostate cancer with bone metastasis. British Journal of Urology. 100(s2). 60–62. 12 indexed citations

11.

Halapas, Antonios, Peter Lembessis, Iordanis Mourouzis, et al.. (2007). Experimental hyperthyroidism increases expression of parathyroid hormone‐related peptide and type‐1 parathyroid hormone receptor in rat ventricular myocardium of the Langendorff ischaemia–reperfusion model. Experimental Physiology. 93(2). 237–246. 8 indexed citations

12.

Lembessis, Peter, Pavlos Msaouel, Antonis Halapas, et al.. (2007). Combined androgen blockade therapy can convert RT-PCR detection of prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA) transcripts from positive to negative in the peripheral blood of patients with clinically localized prostate cancer and increase biochemical failure-free survival after curative therapy. Clinical Chemistry and Laboratory Medicine (CCLM). 45(11). 1488–94. 22 indexed citations

13.

Koutsilieris, Michael, John Bogdanos, Constantine Milathianakis, et al.. (2006). Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach. Expert Opinion on Investigational Drugs. 15(7). 795–804. 13 indexed citations

14.

Mitsiades, Constantine S., Peter Lembessis, Antigone Sourla, & Constantine Milathianakis. (2004). Molecular staging by RT-PCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer. Clinical & Experimental Metastasis. 21(6). 495–505. 43 indexed citations

15.

Τέντα, Ρωξάνη, et al.. (2003). Bone microenvironment‐related growth factors modulate differentially the anticancer actions of zoledronic acid and doxorubicin on PC‐3 prostate cancer cells. The Prostate. 59(2). 120–131. 26 indexed citations

16.

Lembessis, Peter, Spyros Milingos, S. Michalas, et al.. (2003). Urokinase‐Type Plasminogen Activator and Insulin‐Like Growth Factor‐Binding Protein 3 mRNA Expression in Endometriotic Lesions and Eutopic Endometrium. Annals of the New York Academy of Sciences. 997(1). 223–228. 18 indexed citations

17.

Macleod, John, Peter Lembessis, J. R. Hamilton, & William S. Powell. (1999). 5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates Isotonic Volume Reduction of Guinea Pig Jejunal Crypt Epithelial Cells. Journal of Pharmacology and Experimental Therapeutics. 291(2). 511–516. 8 indexed citations

18.

Kilpatrick, Michael W., Peter Lembessis, Elise Rose, & Petros Tsipouras. (1999). A Novel G to A Substitution at Nucleotide 1734 of the FBN1 Gene Predicting a C534Y Mutation Responsible for Marfan Syndrome. Human Heredity. 49(3). 176–177. 4 indexed citations

19.

Lembessis, Peter, et al.. (1999). Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen. Clinical & Experimental Metastasis. 17(10). 823–830. 19 indexed citations

20.

Lembessis, Peter, et al.. (1992). Differences in Ca2+-mediation of hypotonic and Na+-nutrient regulatory volume decrease in suspensions of jejunal enterocytes. The Journal of Membrane Biology. 130(1). 23–31. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact